Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects
Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects
Title
Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects
Author
Kim Y, Jeon JY, Kim EY, Lim CH, Jang HB, Kim MG
Year
2017
Journal
Clin Pharmacol Drug Dev
Details
2017 Sep;6(5):499-507
DOI
10.1002/cpdd.343
첨부파일
첨부파일이(가) 없습니다.
다음글
Associations of fatty acids with cognition, psychopathology, and brain-derived neurotrophic factor levels in patients with first-episode schizophrenia and related disorders treated with paliperidone extended release
김민걸
2021-09-18 23:39:31.0
이전글
Phase I and Pharmacokinetic Drug-Drug Interaction Study of Metformin, Losartan, and Linagliptin Coadministered with DW1029M in Healthy Volunteers